기본 정보
- CAS
43054-45-1- 표준 SMILES
CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1.O=C(O)CC(O)(CC(=O)O)C(=O)O- InChIKey
PYTMYKVIJXPNBD-UHFFFAOYSA-N- 분자식
- C32H36ClNO8
- 평균 분자량
- 598.1 g/mol
- 단동위원소 질량
- 597.2129448
개요
Clomiphene Citrate can cause cancer and developmental toxicity according to state or federal government labeling requirements.
이름 및 식별자
- 우선 이름
- Clostilbegit
- IUPAC
- 2-[4-(2-chloro-1,2-diphenylethenyl)phenoxy]-N,N-diethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid
- 현지명
- 클로미펜구연산
- 영어명
- Clomiphene Citrate
- 분자식
- C26H28ClNO.C6H8O7
- 분자량
- 598.088
이름 및 동의어
CLOMIPHENE CITRATEClomifene citrate50-41-9ClostilbegytIkaclomineMilophenePergotimeClomifeni citrasClomphidIkaclomin43054-45-11B8447E7YI
이름 더 보기
클로미펜구연산Testosterone Undecanteclomifene dihydroen citrate
NSC-35770MER-41MRL-412-(p-(2-Chloro-1,2-diphenylvinyl)phenoxy)triethylamine citrate (1:1)ClostilbegitClopheneNSC35770Clomiphene Citrtae
데이터베이스 식별자
- CAS
43054-45-1、50-41-9- PubChem CID
- 60974
- DTXSID
DTXSID8020337- ChEMBL
CHEMBL3185958- EC Number
- 200-035-3
물성
구조 계산 물성
- 극성 표면적
- 145 Ų
- 수소 결합 공여자 수
- 4
- 수소 결합 수용자 수
- 9
- 회전 가능 결합 수
- 14
- 무거운 원자 수
- 42
- 형식 전하
- 0
- 복잡도
- 708
실험 및 물리화학적 성질
Human Drugs
FDA approved drugs -> Active ingredient
FDA approved drugs -> Active ingredient
Endocrine DisruptorsPotential endocrine disrupting compound
물리화학적 성질
- InChIKey
- PYTMYKVIJXPNBD-BTKVJIOYSA-N
- SMILES
- C(=C(/Cl)\C1=CC=CC=C1)(/C1=CC=CC=C1)\C1C=CC(OCCN(CC)CC)=CC=1.C(O)(C(=O)O)(CC(=O)O)CC(=O)O
안전 및 규제
안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
GHS 분류
GHS Classification
Danger
H360 (10%): May damage fertility or the unborn child [Danger Reproductive toxicity]
P203, P280, P318, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 50 reports by companies from 10 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
유해성 정보
Regulatory Information
Hazard Traits - Carcinogenicity; Developmental Toxicity
Clomiphene citrate: Does not have an individual approval but may be used under an appropriate group standard
Other Safety InformationIMAP assessments - Ethanamine, 2-[4-(2-chloro-1,2-diphenylethenyl)phenoxy]-N,N-diethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1): Human health tier I assessment
Hazard Classes and CategoriesRepr. 1A (10%)
독성 정보
Carcinogen Classification
Clomiphene citrate
Group 3: Not classifiable as to its carcinogenicity to humans
Volume 21: (1979) Sex Hormones (II)
1987
1987
Drug Induced Liver Injury
Drug Induced Liver Injury Rank (DILIrank 2.0)
Clomiphene citrate
vLess-DILI-concern
3
Warnings & precautions
DOI:10.1016/j.drudis.2016.02.015
화학 및 산업
약리 정보
FDA Pharmacological Classification
CLOMIPHENE CITRATE
Estrogen Agonist/Antagonist [EPC]; Selective Estrogen Receptor Modulators [MoA]
CLOMIPHENE CITRTAE
Estrogen Agonist/Antagonist [EPC]; Selective Estrogen Receptor Modulators [MoA]
MeSH Pharmacological Classification
Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds.
Compounds which increase the capacity to conceive in females.
A structurally diverse group of compounds distinguished from ESTROGENS by their ability to bind and activate ESTROGEN RECEPTORS but act as either an agonist or antagonist depending on the tissue type and hormonal milieu. They are classified as either first generation because they demonstrate estrogen agonist properties in the ENDOMETRIUM or second generation based on their patterns of tissue specificity. (Horm Res 1997;48:155-63)
공급사15 곳
Anhui Yiao New Material Technology Co., Ltd+86-18033737140 +86-17354101231 · [email protected]
重庆康洲智通医药科技有限公司173-08362167 17308362167 · [email protected]
宝鸡缔都医药化工有限公司029-81145305 17791533577 · [email protected]
湖北鑫源顺医药化工有限公司13971561712, 13995564702, 027-50664929 · [email protected]
上海石洋化工有限公司021-56795766 · [email protected]
池州凯隆进出口贸易有限公司[email protected]
Wuhan Nutra Biotechnology Co.,Ltd[email protected]
관련 반응
0건
현재 필터 조건에 해당하는 반응 기록이 없습니다.
화합물 노트
불러오는 중…